In the vast and ever-evolving world of biotechnology, the analysis of Glucagon-like Peptide-1 (GLP-1) therapeutics is undergoing a revolution. As these therapeutics gain popularity, due to their profound impact on sugar metabolism and chronic weight management, the demand for precision and efficiency in their biopharmaceutical analysis is escalating. To meet this demand, the industry is […]